ALDX Aldeyra Therapeutics: Prakiraan wutah bathi kanggo taun ngarep

Simbol lan logo merek Aldeyra Therapeutics (ALDX)

Aldeyra Therapeutics (ALDX) relies on competent management with transparent relations with the FDA. The monopoly status of its unique eye drops will allow the company to independently determine the cost of therapy. This 12-month EPS growth chart demonstrates scaling potential, where 15.30 serves as the base parameter value. High readiness of contract manufacturing plants guarantees the rapid ramp-up of molecule synthesis without downtime.

Aldeyra Therapeutics Inc. (ALDX): Prakiraan wutah bathi resik saben saham kanggo taun ngarep saka 04.07.2022 nganti 16.11.2026

Rincian metrik lan analitis perusahaan Aldeyra Therapeutics (ALDX)

Analisis fundamental perusahaan:ALDX, Aldeyra Therapeutics Inc.
Produk dadi Aldeyra

The metric is calculated as the weighted average of analysts' expectations for the change in earnings per share next year relative to current values. This indicator filters out market noise, identifying a steady professional consensus regarding future returns. For Aldeyra Therapeutics (ALDX), such forecasts depend directly on the successful certification of innovative ophthalmological drugs. The price action of the forward net income growth rate reflects market confidence in overcoming regulatory barriers.

Analisis pesaing Aldeyra Therapeutics

ALC (Alcon Corp) - Prakiraan wutah bathi kanggo taun ngarep|Bausch + Lomb Corporation (BLCO) - Prakiraan konsensus wutah bathi saben saham kanggo taun ngarep|Prakiraan wutah bathi kanggo taun ngarep GKOS|Prakiraan wutah bathi kanggo taun ngarep Apellis Pharmaceuticals, Inc. (APLS)|Prakiraan wutah bathi kanggo taun ngarep BLTE (Belite Bio)|OCUL - Prakiraan wutah bathi saben saham kanggo taun ngarep|HROW - Prakiraan wutah bathi resik saben saham kanggo taun ngarep|Dinamika bathi saben saham sing diarepake ing taun ngarep VRDN (Viridian Therapeutics)|LENZ (LENZ Therapeutics, Inc.) - Prakiraan wutah bathi saben saham kanggo taun ngarep|Oculis Holding AG - Dinamika bathi saben saham sing diarepake ing taun ngarep|Prakiraan wutah bathi resik saben saham kanggo taun ngarep eyepointpharma.com|Prakiraan wutah bathi kanggo taun ngarep Kodiak Sciences Inc.|Prakiraan wutah bathi kanggo taun ngarep KALA|IRD - Prakiraan wutah bathi resik saben saham ing taun ngarep|Prakiraan wutah bathi kanggo taun ngarep OKYO (OKYO Pharma Limited)|ADVM - Prakiraan wutah bathi saben saham kanggo taun ngarep|OTLK: Prakiraan wutah bathi saben saham kanggo taun ngarep|CLSD (Clearside) - Proyeksi kacepetan wutah bathi saben saham kanggo taun ngarep|NBY: Prakiraan wutah bathi kanggo taun ngarep|Kiora Pharma (KPRX) - Prakiraan wutah bathi kanggo taun ngarep|ALIM (alimerasciences.com) - Prakiraan wutah bathi kanggo taun ngarep|eyenovia.com (EYEN) - Prakiraan konsensus wutah bathi saben saham kanggo taun ngarep|Prakiraan wutah bathi kanggo taun ngarep GHSI|OCUP (Ocuphire) - Dinamika bathi saben saham sing diarepake ing taun ngarep|Prakiraan wutah bathi kanggo taun ngarep OPT (Opthea Ltd)